Investing.com — AirSculpt Technologies, a provider of aesthetic body-contouring procedures, saw its shares fall by 32% in premarket trading after it reported preliminary 2024 results that fell short of the company’s guidance and analyst estimates.
The company’s preliminary revenue for 2024 is reported at $180 million, which is lower than the forecast range of $183 million to $189 million. The average analyst estimate for the period was $185.4 million.
Additionally, the 2024 adjusted Ebitda (Earnings before interest, tax, depreciation, and amortization) is projected at $20.5 million. This is less than AIRS’s own projection of $23 million to $28 million and the analyst estimate of $24.2 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.